Today: 16 April 2026
Australia stock market today: ASX 200 closes higher as tech rebounds; BlueScope pushes back on $13.2b bid

Australia stock market today: ASX 200 closes higher as tech rebounds; BlueScope pushes back on $13.2b bid

Sydney, Jan 8, 2026, 21:54 AEDT — Market closed.

  • The S&P/ASX 200 finished up 0.29% at 8,720.8 after trading between 8,693.7 and 8,739.2.
  • BlueScope rejected a A$13.2 billion takeover approach from SGH and U.S.-based Steel Dynamics.

Australian shares ended higher on Thursday, lifted by a second straight rise in tech and health stocks while miners eased. The S&P/ASX 200 closed up 0.29% at 8,720.8, with information technology up 1.73% and healthcare up 1.64%, even as materials fell 1.23%.

The rotation matters right now because investors are trying to read the rate path off a handful of fresh inflation signals, and the RBA has pushed back on any victory laps. Deputy Governor Andrew Hauser said inflation above 3% was still too high after data showed annual CPI inflation slowed to 3.4% in November, while the central bank’s core measure — the trimmed mean, which strips out price spikes — eased to 3.2%.

Energy names were a quieter drag as oil swung around the $60-a-barrel mark and the Australian dollar slipped to about 67 U.S. cents. “If oil stays below $60, energy companies could be significantly affected,” Zavier Wong, a market analyst at eToro, told the Australian Broadcasting Corporation, flagging the risk that more supply — including from Venezuela — keeps a lid on prices. ABC

On the single-stock board, Mesoblast jumped 8.8% and buy-now-pay-later firm Zip Co gained 7.5%, while shipbuilder Austal climbed 6.4%. Ansell dropped 6.2%, Capricorn Metals fell 5.5% and Lynas Rare Earths slid 5.1%.

BlueScope Steel also stayed in focus after it rejected a non-binding $30-a-share proposal from a consortium of SGH and Steel Dynamics. Chair Jane McAloon called it “an attempt to take BlueScope from its shareholders on the cheap,” adding that the structure would leave shareholders wearing the dividend deductions while the deal drags on. BlueScope said a return to historical average steel spreads (the gap between steel prices and input costs) and foreign-exchange rates could lift annual EBIT by A$400 million to A$900 million versus FY2025. BlueScope

Glove maker Ansell said CEO Neil Salmon will retire after 13 years with the company, and Nathalie Ahlström, most recently CEO and president of Finland’s Fiskars Group, will take over on Feb. 16 after a transition starting Jan. 26. Chair Nigel Garrard said Ahlström brings leadership experience and a track record in “complex global markets”. ASX Announcements

Capricorn Metals said December-quarter output at its Karlawinda Gold Project was 30,476 ounces, keeping it on track for the upper end of its FY26 guidance. It forecast all-in sustaining costs — a per-ounce measure that includes sustaining capital spend — of $1,530 to $1,630, with full operational and cost details due in its quarterly report later this month.

But the tape is still jumpy. A hot U.S. jobs print or another leg down in commodities could shove bond yields higher again and pressure the very sectors that steadied the market late this week, while takeover talk around BlueScope risks cooling if bidders decide the maths no longer works.

Stock Market Today

  • Telecom Italia TIT.BR stock rises 0.49% in EURONEXT pre-market trading
    April 15, 2026, 9:54 PM EDT. TIT.BR stock of Telecom Italia S.p.A. gained 0.49% pre-market on EURONEXT to €0.3069. Trading volume surged to 553 million shares, 33% above average, signaling increased investor interest. The stock jumped 9.72% in one day and 30.65% over 12 months, reflecting strong recovery from its 52-week low of €0.1975. With a market capitalization of €6.32 billion, Telecom Italia remains influential in Europe's Communication Services sector. The company faces moderate leverage with a debt-to-equity ratio of 1.13 and a negative earnings per share (EPS) of -€0.53, suggesting some profitability challenges. Despite this, analyst consensus grades the stock as a HOLD, supported by reasonable valuation metrics and steady trading momentum ahead of the session.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Applied Digital stock: APLD jumps after-hours on revenue beat, $5B AI lease and fresh funding
Previous Story

Applied Digital stock: APLD jumps after-hours on revenue beat, $5B AI lease and fresh funding

Meta stock slips premarket as China opens probe into Manus AI acquisition
Next Story

Meta stock slips premarket as China opens probe into Manus AI acquisition

Go toTop